Product Information
BUMETANIDE 1 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1585 per EA under NDC 68382052605. Its NADAC has been published 267 times since May 27, 2020.
FDA first approved this application on Apr 30, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the bumetanide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382052605
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
BUMETANIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202900FDA Approved
4/30/2018
TE Code
AB
On Market Since
5/1/2018
Pharmacological Classes
Price Statistics
The NADAC for BUMETANIDE 1 MG TABLET has been published 267 times since May 27, 2020, and over the history we have for it it has declined 60.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1585 per EA |
|---|---|
| All-time high | $0.3966 (Jun 10, 2020) |
| All-time low | $0.1247 (Nov 20, 2024) |
| Median price | $0.2169 |
| Average price | $0.2256 |
| Largest weekly change | +76.2% (Aug 21, 2024) |
| Weeks tracked | 267 |
| Tracking since | May 27, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-23.5%
5Y
-40.2%
All
-60.0%
Last surveyed Jul 2, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUMETANIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUMETANIDE 1 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1585 per EA (NDC 68382052605), effective Jul 2, 2025.
How has the price of BUMETANIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUMETANIDE 1 MG TABLET has declined 60.0%. It has been tracked across 267 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for BUMETANIDE 1 MG TABLET?
Since May 27, 2020, the NADAC for BUMETANIDE 1 MG TABLET has ranged from a low of $0.1247 (Nov 20, 2024) to a high of $0.3966 (Jun 10, 2020), with a median of $0.2169 per EA.
Are there cheaper alternatives to BUMETANIDE 1 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUMETANIDE 1 MG TABLET, is $0.1075 per EA — about 32% below BUMETANIDE 1 MG TABLET.
Who manufactures BUMETANIDE 1 MG TABLET?
BUMETANIDE 1 MG TABLET (NDC 68382052605) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.